Joel Isaacson & Co’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-10,302
| Closed | -$1.02M | – | 215 |
|
|
2019
Q3 | $1.02M | Sell |
10,302
-14
| -0.1% | -$1.33K | 0.15% | 72 |
|
|
2019
Q2 | $954K | Sell |
10,316
-462
| -4% | -$43.9K | 0.14% | 73 |
|
|
2019
Q1 | $1.02M | Buy |
10,778
+150
| +1% | +$13.1K | 0.15% | 81 |
|
|
2018
Q4 | $929K | Sell |
10,628
-474
| -4% | -$35K | 0.15% | 82 |
|
|
2018
Q3 | $994K | Hold |
11,102
| – | – | 0.16% | 67 |
|
|
2018
Q2 | $882K | Sell |
11,102
-3,060
| -22% | -$254K | 0.15% | 73 |
|
|
2018
Q1 | $1.26M | Hold |
14,162
| – | – | 0.22% | 48 |
|
|
2017
Q4 | $1.48M | Hold |
14,162
| – | – | 0.26% | 44 |
|
|
2017
Q3 | $2.06M | Sell |
14,162
-500
| -3% | -$68.1K | 0.38% | 31 |
|
|
2017
Q2 | $1.9M | Sell |
14,662
-400
| -3% | -$49K | 0.36% | 33 |
|
|
2017
Q1 | $1.87M | Hold |
15,062
| – | – | 0.37% | 33 |
|
|
2016
Q4 | $1.74M | Hold |
15,062
| – | – | 0.35% | 34 |
|
|
2016
Q3 | $1.57M | Hold |
15,062
| – | – | 0.32% | 34 |
|
|
2016
Q2 | $1.49M | Sell |
15,062
-91
| -0.6% | -$9.41K | 0.32% | 33 |
|
|
2016
Q1 | $1.52M | Hold |
15,153
| – | – | 0.34% | 34 |
|
|
2015
Q4 | $1.81M | Sell |
15,153
-300
| -2% | -$34.7K | 0.45% | 26 |
|
|
2015
Q3 | $1.67M | Sell |
15,453
-751
| -5% | -$93.2K | 0.45% | 26 |
|
|
2015
Q2 | $1.88M | Sell |
16,204
-11,624
| -42% | -$1.33M | 0.48% | 23 |
|
|
2015
Q1 | $3.21M | Sell |
27,828
-458
| -2% | -$54.7K | 0.81% | 14 |
|
|
2014
Q4 | $3.16M | Sell |
28,286
-117
| -0.4% | -$12.3K | 0.85% | 14 |
|
|
2014
Q3 | $2.69M | Sell |
28,403
-553
| -2% | -$49.9K | 0.82% | 16 |
|
|
2014
Q2 | $2.49M | Buy |
28,956
+2,926
| +11% | +$223K | 0.78% | 18 |
|
|
2014
Q1 | $1.82M | Sell |
26,030
-1,000
| -4% | -$79.2K | 0.61% | 22 |
|
|
2013
Q4 | $2.28M | Buy |
27,030
+1,000
| +4% | +$79.1K | 0.83% | 18 |
|
|
2013
Q3 | $2.01M | Buy |
26,030
+3,200
| +14% | +$224K | 0.82% | 18 |
|
|
2013
Q2 | $1.33M | Buy |
+22,830
| New | +$1.37M | 0.63% | 21 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Joel Isaacson & Co's CELG Position: Q4 2019 in Review
Joel Isaacson & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 10,302 shares — an estimated $1.02M sold.
Joel Isaacson & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.21M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Joel Isaacson & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Joel Isaacson & Co sold 10,302 Celgene Corp shares in Q4 2019, an estimated $1.02M.
- Joel Isaacson & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Joel Isaacson & Co's Celgene Corp position peaked at $3.21M in Q1 2015.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Joel Isaacson & Co's 13F filing for Q4 2019, filed 24 Jan 2020.